Scientists track breast Cancer's genetic evolution in recurrence study
NCT ID NCT02530008
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 600 women whose breast cancer has returned to learn how the cancer changes over time. Participants provide tumor samples and blood, and optionally bone marrow, at multiple points. The goal is to identify genetic markers of cancer progression, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WOMEN WITH SUSPECTED OR CONFIRMED RECURRENT BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States